DCGI

New Delhi: The Drugs Controller General of India (DCGI) on Monday granted permission to Serum Institute of India (SII) to manufacture its COVID-19 vaccine 'Covishield'. As per reports, the DCGI has also asked Bharat Biotech to submit…

New Delhi: In a major development, the Drug Controller General of India (DCGI) has approved the two vaccines, Oxford-AstraZeneca Covishield and Bharat Biotech's Covaxin, for restricted use in India. The DCGI addressed a press conference…

New Delhi: The Subject Expert Committee of Central Drug Standard Control Organisation has approved emergency use of Oxford-AstraZeneca’s ‘Covishield’ vaccine. The final approval, however, rests with the Drugs Controller General of India…

New Delhi: The Serum Institute of India (SII) has applied to the Drugs Controller General of India (DCGI) seeking emergency use authorisation for its COVID-19 vaccine "Covishield" in the country. This comes a day after Pfizer India…

New Delhi: After its parent company secured such clearance in the UK and Bahrain, Pfizer India has become the first pharmaceutical firm to seek from the Drugs Controller General of India (DCGI) an emergency use authorisation for its…